期刊文献+

胃癌组织Oct4和PI3K的表达和相关性

EXPRESSION AND CORRELATION OF OCT4 AND PI3K IN GASTRIC CARCINOMA
下载PDF
导出
摘要 目的:探讨八聚体结合转录因子(Oct4)与磷脂酰肌醇3-激酶(PI3K)在胃癌组织中的表达和意义,并分析二者的相关性。方法:应用免疫组化S-P法检测60例胃癌组织和25例正常胃组织(距癌组织边缘10cm以上的胃组织)Oct4与PI3K蛋白的表达情况。结果:胃癌组织Oct4、PI3K的阳性表达率均明显高于癌旁正常胃组织(P<0.01);胃癌组织Oct4、PI3K的表达均与分化程度、浸润深度、淋巴结转移有关(P<0.05),与年龄和性别无关(P>0.05)。胃癌组织Oct4、PI3K的表达呈正相关关系(r=0.532,P<0.05)。结论:Oct4和PI3K可能与胃癌的发生、发展及浸润转移密切相关。 Objective: To investigate the expression and signif icance of octamer-binding transcription factor(Oct4) and phosphatidyl inositol 3–kinase(PI3K) in gastric carcinoma, and analyze the correlations between them. Methods: S-P immunohistochemical stain was used to detect the expression of Oct4 and PI3 K in 60 cases gastric carcinoma and 25 casesnormal gastric tissues. Results: The positive expression rate of Oct4 and PI3 K in gastric carcinoma was obviously higher than normal gastric tissues(P〈0.01). In gastric carcinoma, the expression of Oct4 and PI3 K were all related to differentiated degree, inf iltration depth and lymph node metastasis(P〈0.05); but not related to age and sex(P〈0.05). In gastric carcinoma, the expression of Oct4 was positively correlated with PI3K(r=0.532,P〈0.05). Conclusions: Oct4 and PI3 K may play important role in development, inf iltration and metastasis of gastric carcinoma.
出处 《承德医学院学报》 2016年第3期187-189,共3页 Journal of Chengde Medical University
关键词 胃癌 OCT4 PI3K Gastric carcinoma Oct4 PI3K
  • 相关文献

参考文献1

二级参考文献30

  • 1Fearon ER;Vogelstein B.A genetic model for colorectal tumorigenesis,1990(05).
  • 2Shaw RJ,Cantley LC.Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature . 2006
  • 3Reuter CW,Morgan MA,Bergmann L.Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies. Blood . 2000
  • 4Ortiz-Vega S,Khokhlatchev A,Nedwidek M,et al.The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Norel. Oncegene . 2002
  • 5Schuell B,Gruenberger T,Scheithauer W,et al.HER2/neuprotein expression in colorectal cancer. BMC Cancer . 2006
  • 6Baldus SE,Schaefer KL,Engers R,et al.Prevalence and heterogeneity of KRAS,BRAF,and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clinical Cancer Research . 2010
  • 7Vakiani E,Solit D B.KRAS and BRAF: Drug targets and predictive biomarkers. Journal of Paleopathology . 2011
  • 8Donninger H,Vos M D,Clark G J.The RASSF1A tumor suppressor. Journal of Cell Science . 2007
  • 9Markowitz SD,Bertagnolli MM.Molecular origins of cancer:Molecular basis of colorectal cancer. The New England Journal of Medicine . 2009
  • 10Oki,E,Oda,S,Maehara,Y,Sugimachi,K.Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair. Oncegene . 1999

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部